Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine wether RAD001 can inhibit growth of tumour cells
and/or stop the formation and activity of bone degrading osteoclasts.